24.03.2026

Value: First-in-class catalytic RNA degradation platform targeting telomere biology without DNA damage.

A highly selective RIBOTAC that degrades TERRA RNA at nanomolar potency via RNase L recruitment. Demonstrates locus-specific activity and efficacy in ALT-positive and telomerase-positive cancer cells, suppressing ALT hallmarks and tumorigenic growth while sparing DNA G-quadruplex structures.

 

Read more here